IVP Ltd Upgraded to Strong Buy on Robust Technicals and Attractive Valuation

Technical Trends Shift to Bullish Momentum

The primary catalyst for the rating upgrade was a marked improvement in IVP’s technical profile. The technical trend has advanced from mildly bullish to bullish, supported by a confluence of positive signals across multiple timeframes. On the weekly chart, the Moving Average Convergence Divergence (MACD) indicator is firmly bullish, while the monthly MACD remains mildly bullish, indicating strengthening momentum over both short and medium terms.

Additional technical indicators reinforce this positive outlook. Bollinger Bands show bullish patterns on both weekly and monthly scales, suggesting increased volatility with upward price movement. Daily moving averages are also bullish, confirming short-term strength. The Know Sure Thing (KST) oscillator is bullish weekly and mildly bullish monthly, further supporting the momentum shift.

While the Relative Strength Index (RSI) on weekly and monthly charts currently shows no clear signal, the overall technical ensemble points to a robust uptrend. The Dow Theory readings remain mildly bullish, and although On-Balance Volume (OBV) lacks a definitive trend, the price action has been strong enough to drive a 16.5% gain in a single day, with the stock closing at ₹189.20, up from ₹162.40 the previous day.

Valuation Upgraded to Very Attractive

Alongside technical improvements, IVP’s valuation grade was upgraded from attractive to very attractive. The company’s price-to-earnings (PE) ratio stands at a modest 10.27, significantly lower than many peers in the Chemicals industry, where valuations often exceed 16 to 60 times earnings. The enterprise value to EBITDA ratio is 8.50, underscoring a reasonable price relative to operating cash flow.

Other valuation metrics further highlight IVP’s appeal. The price-to-book value is 1.36, and the enterprise value to capital employed is a low 1.21, indicating efficient use of capital at a bargain price. The PEG ratio, which adjusts PE for earnings growth, is an exceptionally low 0.15, signalling undervaluation relative to growth prospects. Dividend yield is modest at 0.53%, while return on capital employed (ROCE) and return on equity (ROE) are 7.91% and 13.21% respectively, reflecting solid profitability.

Compared to peers such as Sanstar, Stallion India, and Titan Biotech, which trade at very expensive multiples, IVP’s valuation metrics position it as a compelling investment opportunity within the commodity chemicals space.

Financial Trends Reflect Strong Profit Growth

IVP’s financial performance has been a key driver behind the upgrade. The company reported a remarkable 91.36% growth in net profit for the quarter ending March 2026, marking its third consecutive quarter of positive results. Net sales reached a record ₹164.44 crores, while PBDIT (profit before depreciation, interest and taxes) hit ₹13.70 crores, the highest in recent history.

Operating profit to interest ratio surged to 10.00 times, indicating robust earnings relative to debt servicing costs. This financial strength supports the company’s ability to sustain growth and invest in future opportunities.

Despite a one-year stock return of -4.28%, IVP’s profits have risen by 68.2% over the same period, highlighting a disconnect between earnings growth and market price. The PEG ratio of 0.2 further emphasises the undervaluation relative to earnings momentum.

However, investors should note that IVP has underperformed the Sensex and BSE500 benchmarks over the last three years, with a 3-year return of 15.02% compared to Sensex’s 19.00%, and a 10-year return of 60.88% versus Sensex’s 188.16%. This underperformance warrants cautious optimism despite recent improvements.

Technical and Valuation Synergy Supports Upgrade

The upgrade to a Strong Buy rating with a Mojo Score of 80.0 reflects the combined impact of improved technicals and very attractive valuation. The technical grade’s shift to bullish aligns with the stock’s recent price surge, including a 17.99% return over the past week compared to Sensex’s 2.03%. The valuation upgrade recognises IVP’s discount to peers and strong profitability metrics.

IVP’s micro-cap status and promoter majority ownership add to its appeal for investors seeking growth opportunities in the commodity chemicals sector. The company’s current price of ₹189.20 is close to its 52-week high of ₹204.95, indicating positive market sentiment.

Risks and Considerations

While the upgrade is well supported by recent data, investors should be mindful of IVP’s historical underperformance relative to broader market indices. The stock’s 1-year return of -4.28% trails the Sensex’s -6.17%, but the 3-year and 5-year returns also lag the benchmark. This suggests that despite strong quarterly earnings and improved technicals, the stock may face challenges in sustaining long-term outperformance.

Additionally, the relatively modest dividend yield of 0.53% may not appeal to income-focused investors. The company’s ROCE of 7.91% is respectable but not outstanding, indicating room for operational efficiency improvements.

Overall, IVP Ltd’s upgrade to Strong Buy by MarketsMOJO reflects a positive shift in fundamentals and market sentiment, making it a compelling candidate for investors seeking exposure to the commodity chemicals sector with a focus on growth and value.

Conclusion

IVP Ltd’s recent upgrade from Buy to Strong Buy is underpinned by a comprehensive improvement across four key parameters: technical indicators, valuation metrics, financial trends, and quality assessments. The bullish technical signals, very attractive valuation ratios, and strong quarterly financial results combine to present a compelling investment case. While historical underperformance relative to benchmarks remains a cautionary note, the company’s current momentum and fundamentals suggest potential for sustainable gains ahead.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →